| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
23,774 | 22,238 | 20,656 | 18,332 | 14,817 | 10,883 | 0 | 0 | 0 |
Operating expenses | ||||||||
Research and development | ||||||||
87,334 | 82,416 | 78,911 | 68,857 | 56,966 | 45,122 | 0 | 0 | 0 |
General and administrative | ||||||||
31,646 | 27,026 | 23,193 | 19,392 | 16,022 | 13,673 | 0 | 0 | 0 |
Total operating expenses | ||||||||
118,980 | 109,442 | 102,104 | 88,249 | 72,988 | 58,795 | 0 | 0 | 0 |
Loss from operations | ||||||||
-95,206 | -87,204 | -81,448 | -69,917 | -58,171 | -47,912 | 0 | 0 | 0 |
Other income (expense), net: | ||||||||
Change in fair value of convertible notes payable | ||||||||
- | 9,758 | 0 | 0 | 0 | - | - | - | - |
Interest expense | ||||||||
- | 182 | 0 | 0 | 0 | - | - | - | - |
Interest income | ||||||||
4,326 | 4,267 | 3,984 | 3,439 | 2,253 | 1,875 | 0 | 0 | 0 |
Total other income (expense), net | ||||||||
7,276 | -5,673 | -5,956 | -6,501 | -10,637 | 1,875 | 0 | 0 | 0 |
Net loss and net loss attributable to common stockholders | ||||||||
-87,930 | -92,877 | -87,404 | -76,418 | -68,808 | -46,037 | 0 | 0 | 0 |
Net loss per share attributable to common stockholders- basic and diluted | ||||||||
-0.52 | 0.58 | -0.41 | -0.39 | -1.99 | -0.98 | -0.62 | -0.75 | -0.57 |
Weighted average shares of common stock outstanding- basic and diluted | ||||||||
51,312 | 51,338 | 50,623 | 50,035 | 15,967 | 15,850 | 15,816 | 15,730 | 15,704 |